PEDIATRICS Vol. 69 No. 3 March 1982, pp. 381-382
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucey, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lucey, J. F.

Bilirubin and Brain Damage— A Real Mess

Jerold F. Lucey MD

What to do for the low-birth-weight jaundiced neonate has been a subject of debate for 30 years.

It is generally agreed that the "20 mg/100 ml level" for an exchange transfusion in a full-term infant with hemolytic disease, has been effective in avoiding deaths due to kernicterus and brain damage due to bilirubin neurotoxicity. It's not perfect, but it has been effective. This is amazing because the original studies, judged by modern standards, would not be acceptable today.1

Trouble first began when this concept was extended to jaundiced low-birth-weight infants. It was assumed that "the level" should be lower in smaller infants.




This article has been cited by other articles:


Home page
 PediatricsHome page
R. P. Wennberg and C. E. Ahlfors
A Different View on Bilirubin Binding
Pediatrics, August 1, 2006; 118(2): 846 - 847.
[Full Text] [PDF]

Home page
 PediatricsHome page
S. B. Amin, C. Ahlfors, M. S. Orlando, L. E. Dalzell, K. S. Merle, and R. Guillet
Bilirubin and Serial Auditory Brainstem Responses in Premature Infants
Pediatrics, April 1, 2001; 107(4): 664 - 670.
[Abstract] [Full Text] [PDF]